Acorai
About
Acorai is a MedTech company developing an AI-powered, non-invasive cardiac and pulmonary pressure monitoring device for heart failure management. Headquartered in Sweden, Acorai has 13 employees.
We have validated our technology in clinical trials with 2,000 patients (20 clinical sites, 6 countries), received FDA Breakthrough Device designation and target commercialization by 2027.
2024 Switch Top 50 finalist, 2025 2x CHISEL Awards winner.
Representatives
Co-founder & COO
Acorai